LANTERN PHARMA INC

LTRNNASDAQ

🏆 #3534 by market capEarnings Aug 13US Equity

$2.78▼ $0.03 (−1.07%)

🌙 After hours$2.77▼ 0.25%Regular close · extended-hours price shown

1h—

24h▼ 1.1%

7d▲ 0.0%

14d▲ 8.6%

30d▼ 19.9%

1y▼ 37.6%

🏦Market Cap

$35M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

66

Fair

Earnings

Q2 · 2026Reported 2026-05-15

Earnings Per Share

Actual

-0.30

Expected

-0.36

beat

+16.70%

YoY +28.60%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.30

beat

Q1 2026

-0.36

beat

Q4 2025

-0.39

beat

Q3 2025

-0.40

beat